Prediction of Permeability and Efflux Using Multitask Learning
Artikel i vetenskaplig tidskrift, 2025

In silico prediction of cell membrane permeability is crucial in drug discovery, since a compound's permeation through membranes influences parameters such as its in vivo efficacy, bioavailability, and pharmacokinetics. This study investigates the use of multitask graph neural networks to predict a selection of permeability-related endpoints. The study utilized a harmonized, single-laboratory internal data set of over 10K compounds measured in human colorectal adenocarcinoma (Caco-2) and Madin-Darby canine kidney (MDCK) cell lines, routinely employed in experimental assays for drug permeability and efflux. This data set is an order of magnitude larger than comparable public collections, thus providing greater statistical power and a consistent error profile for model development. A series of multitask learning (MTL) models trained on such data were benchmarked against single-task approaches and evaluated on an external public data set to investigate the model's applicability domain. The comparison between the performance of single- and multitask models suggests that MTL can achieve higher accuracy by leveraging shared information across endpoints. MTL is also shown to perform better when augmented with molecular features. In particular, the inclusion of pKa and LogD, is shown to improve the accuracy of both permeability and efflux endpoints. This work presents benchmarking results of models utilizing different data splitting strategies, accompanied by guidelines for optimal validation in the context of MTL.

Permeability

Antibiotic resistance

Assays

Peptides and proteins

Cells

Författare

Philip Ivers Ohlsson

Göteborgs universitet

Student vid Chalmers

AstraZeneca AB

Gian Marco Ghiandoni

AstraZeneca AB

Susanne Winiwarter

AstraZeneca AB

Rocio Mercado

Göteborgs universitet

Chalmers, Data- och informationsteknik, Data Science och AI

Vigneshwari Subramanian

AstraZeneca AB

ACS Omega

24701343 (eISSN)

Vol. 10 45 54148-54159

Ämneskategorier (SSIF 2025)

Farmaceutiska vetenskaper

Farmakologi och toxikologi

DOI

10.1021/acsomega.5c04861

Mer information

Senast uppdaterat

2025-12-12